Company / Operating Income
Innoviva, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$163.7M
FY2025
5-year range
$113.9M / $375.1M
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#29 of 204
Health Care
What the data says
Innoviva, Inc.'s operating income of $164M is higher than 86% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 9 years, ranging from $109M in FY2018 to $375M in FY2021.
Based on SEC 10-K filings.
$164M in FY2025 with a 5-year CAGR of -12.6%. Top quartile in the Health Care sector.
Improved from $114M to $164M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -12.6%
- 10-Year CAGR
- -
Sector benchmark
+52.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -12.6%, indicating a declining trend.
- In FY2025, operating income decreased 1.9% year-over-year.
- Ranks #29 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $163.7M | -1.9% |
| FY2024 | $166.9M | +46.5% |
| FY2023 | $113.9M | - |
| FY2022 | - | - |
| FY2021 | $375.1M | +16.8% |
| FY2020 | $321.1M | +74.9% |
| FY2019 | $183.6M | +68.5% |
| FY2018 | $109.0M | -40.6% |
| FY2017 | $183.6M | +68.5% |
| FY2016 | $109.0M | +245.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026